Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass Surgery Incidence, Risk Factors, Time Trends, and Outcomes

被引:157
作者
Mehta, Rajendra H. [1 ]
Sheng, Shubin [1 ]
O'Brien, Sean M. [1 ]
Grover, Frederick L. [2 ]
Gammie, James S. [3 ]
Ferguson, T. Bruce [4 ]
Peterson, Eric D. [1 ]
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[3] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[4] E Carolina Univ, Greenville, NC USA
关键词
bypass; coronary disease; bleeding; outcomes; reoperation; OPERATIVE MORTALITY; ADVERSE OUTCOMES; CARDIAC-SURGERY; REEXPLORATION; TRANSFUSION; CLOPIDOGREL; HEMORRHAGE; ASPIRIN; REVASCULARIZATION; REQUIREMENTS;
D O I
10.1161/CIRCOUTCOMES.109.858811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Reoperation for bleeding represents an important complication in patients undergoing coronary artery bypass surgery (CABG). Yet, few studies have characterized risk factors and patient outcomes of this event. Methods and Results-We evaluated 528 686 CABG patients at >800 hospitals in the Society of Thoracic Surgeons National Cardiac Database (2004 to 2007). Clinical features and in-hospital outcomes were evaluated in patients with and without reoperation for bleeding after CABG. Logistic regression was used to identify predictors of risk of this event and to estimate weights for an additive risk score. A total of 12 652 CABG patients (2.4%) required reoperation for bleeding. These rates remained fairly stable over time (2.2%, 2.3%, 2.5%, and 2.4% from 2004 to 2007, respectively). Although overall operative mortality was 4.5-fold higher in patients requiring reoperation for bleeding versus those who did not (2.0% versus 9.1%), this mortality risk declined significantly over time (11.3%, 9.5%, 8.8%, and 8.2% from 2004 to 2007, respectively, P for trend=0.0006). Factors associated with higher risk for reoperation were identified by multivariable analysis (c statistic=0.60) and summarized into a simple bedside risk score. The risk-score performed well when tested in the validation set (Hosmer-Lemeshow P=0.16). Conclusions-Reoperation for bleeding remains an important morbid event after CABG. Nonetheless, death in patients with this complication has decreased over time. Our risk tool should allow estimation of patients risk for reoperation for bleeding and promote preventive measures when feasible in this at-risk group. (Circ Cardiovasc Qual Outcomes. 2009;2:583-590.)
引用
收藏
页码:583 / 590
页数:8
相关论文
共 25 条
[1]   Clinical overview of promising nonthienopyridine antiplatelet agents [J].
Angiolillo, Dominick J. ;
Guzman, Luis A. .
AMERICAN HEART JOURNAL, 2008, 156 (02) :S23-S28
[2]   ADP receptor antagonism - What's in the pipeline? [J].
Angiolillo, Dominick J. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (06) :423-432
[3]   Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease [J].
Chan, Mark Y. ;
Cohen, Mauricio G. ;
Dyke, Christopher K. ;
Myles, Shelley K. ;
Aberle, Laura G. ;
Lin, Min ;
Walder, James ;
Steinhubl, Steven R. ;
Gilchrist, Ian C. ;
Kleiman, Neal S. ;
Vorchheimer, David A. ;
Chronos, Nicholas ;
Melloni, Chiara ;
Alexander, John H. ;
Harrington, Robert A. ;
Tonkens, Ross M. ;
Becker, Richard C. ;
Rusconi, Christopher P. .
CIRCULATION, 2008, 117 (22) :2865-2874
[4]   Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes [J].
Choong, Cliff K. ;
Gerrard, Caroline ;
Goldsmith, Kimberley A. ;
Dunningham, Helen ;
Vuylsteke, Alain .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (05) :834-838
[5]   Reexploration for hemorrhage following coronary artery bypass grafting - Incidence and risk factors [J].
Dacey, LJ ;
Munoz, JJ ;
Baribeau, YR ;
Johnson, ER ;
Lahey, SJ ;
Leavitt, BJ ;
Quinn, RD ;
Nugent, WC ;
Birkmeyer, JD ;
O'Connor, GT .
ARCHIVES OF SURGERY, 1998, 133 (04) :442-446
[6]   Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients [J].
Despotis, GJ ;
Filos, KS ;
Zoys, TN ;
Hogue, CW ;
Spitznagel, E ;
Lappas, DG .
ANESTHESIA AND ANALGESIA, 1996, 82 (01) :13-21
[7]   Prediction of operative mortality after valve replacement surgery [J].
Edwards, FH ;
Peterson, ED ;
Coombs, LP ;
DeLong, ER ;
Jamieson, WRE ;
Shroyer, ALW ;
Grover, FL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) :885-892
[8]   A decade of change - Risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute [J].
Ferguson, TB ;
Hammill, BG ;
Peterson, ED ;
DeLong, ER ;
Grover, FL .
ANNALS OF THORACIC SURGERY, 2002, 73 (02) :480-489
[9]   Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical Revascularization for non-ST-elevation acute coronary syndrome - The Clopidogrel in Unstable Angina to prevent Recurrent Ischemic Events (CURE) trial [J].
Fox, KAA ;
Mehta, SR ;
Peters, R ;
Zhao, F ;
Lakkis, N ;
Gersh, BJ ;
Yusuf, S .
CIRCULATION, 2004, 110 (10) :1202-1208
[10]   Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass [J].
Frankel, TL ;
Stamou, SC ;
Lowery, RC ;
Kapetanakis, EI ;
Hill, PC ;
Haile, E ;
Corso, PJ .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (03) :494-500